<DOC>
	<DOCNO>NCT01113619</DOCNO>
	<brief_summary>This Phase 2 study design assess ability RP-G28 improve lactose digestion tolerance .</brief_summary>
	<brief_title>Effectiveness , Safety Tolerability Study RP-G28 Symptoms Associated With Lactose Intolerance</brief_title>
	<detailed_description>Lactose intolerance common gastrointestinal ( GI ) disorder develop lactose maldigesters consume much lactose lactose add previously low-lactose diet . Lactose intolerance characterize one cardinal symptom follow ingestion lactose-containing food . These symptom include ; abdominal pain/cramps , bloating , flatulence [ gas ] diarrhea . As , lactose intolerant individual avoid ingestion milk dairy product , others substitute non-lactose containing product diet . Based health implication insufficient calcium intake lifetime , include increase risk osteoporosis hypertension , need medical community tolerable convenient treatment allow level milk dairy product consumption people suffer mild severe lactose intolerance . This study evaluate treatment provide simplified dose regimen well potential extend relief symptom follow limited therapy regimen .</detailed_description>
	<mesh_term>Lactose Intolerance</mesh_term>
	<criteria>Male female subject . Female subject must nonpregnant nonlactating . 18 64 year age inclusive Screening Current recent history intolerance milk dairy product Acceptable Baseline Lactose Intolerance Symptom Scores Acceptable Result Baseline Hydrogen Breath Test Subjects must agree refrain treatment product use lactose intolerance study Disorders know associate abnormal GI motility History surgery alters normal function gastrointestinal tract Past present ; organ transplant , chronic pancreatitis , pancreatic insufficiency , symptomatic biliary disease , Celiac disease , inflammatory bowel disease ( IBD ) , ulcerative colitis , Crohn 's disease , irritable bowel syndrome ( IBS ) Active gastric duodenal ulcer history severe ulcer Diabetes mellitus ( type 1 type 2 ) Congestive Heart Failure History Human Immunodeficiency Virus ( HIV ) , Hepatitis B C Use concurrent therapy ( y ) symptoms lactose intolerance Uncontrolled BP define sit systolic blood pressure ( SBP ) ≥160 mmHg diastolic blood pressure ( DBP ) ≥95 mmHg Visit 1 History ethanol abuse past 12 month History drug abuse within 12 month History presence malignancy within past 5 year ( except basal cell squamous cell carcinoma remove sunexposed area ) Use investigational drug participation investigational study within 30 day prior Screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>lactose maldigestion</keyword>
	<keyword>dairy intolerance</keyword>
	<keyword>intolerance milk</keyword>
	<keyword>intolerance dairy</keyword>
	<keyword>milk intolerance</keyword>
	<keyword>GI disorder</keyword>
	<keyword>lactose metabolism</keyword>
	<keyword>GI symptom dairy ingestion</keyword>
</DOC>